Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

GSK679586

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
The overall efficacy and safety of anti-interleukin (IL)-13 therapies remain to be fully characterized. We conducted a meta… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2014
Highly Cited
2014
BACKGROUND Approximately 5% to 10% of asthmatic patients achieve incomplete symptom control on current therapies. The association… Expand
  • figure 1
  • table II
  • table I
  • figure 2
  • figure 3
Highly Cited
2013
Highly Cited
2013
AIMS IL-13 is implicated as an important mediator of the pathology of asthma. This first clinical study with GSK679586, a novel… Expand
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3